CompanyGraph
At a glance
- Depends onDownstream position: depends on 12 industries, supplies 7
- ScaleRevenue is $22.65B, higher than 95% of all stocks globally
- FinancialsAltman Z-Score 2: grey zone
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
15.20BEUR17.55B · vs all stocks (USD)
Trailing P/E
20.86xvs Medical Care Facilities peers
Revenue (TTM)
19.62BEUR22.65B · vs all stocks (USD)
Profit Margin
3.03%vs Medical Care Facilities peers
Beta
0.9148xvs all stocks
52-Week Change
-9.65%vs all stocks
Market Capitalization
15.20BEUR17.55B · vs all stocks (USD)
Enterprise Value
22.87BEUR26.40B · vs all stocks (USD)
Trailing P/E
20.86xvs Medical Care Facilities peers
PEG Ratio
-1.21xvs Medical Care Facilities peers
Price to Sales (TTM)
0.7809xvs Medical Care Facilities peers
Price to Book (MRQ)
0.9184xvs Medical Care Facilities peers
Enterprise to Revenue
1.17xvs Medical Care Facilities peers
Enterprise to EBITDA
9.67xvs Medical Care Facilities peers
Gross Margin
25.57%vs Medical Care Facilities peers
Profit Margin
3.03%vs Medical Care Facilities peers
Operating Margin
7.52%vs Medical Care Facilities peers
Return on Assets (TTM)
2.60%vs Medical Care Facilities peers
Return on Equity (TTM)
5.30%vs Medical Care Facilities peers
Revenue (TTM)
19.62BEUR22.65B · vs all stocks (USD)
Revenue per Share (TTM)
66.88EURUpdated Jul 15, 2026Quarterly Revenue Growth
1.40%vs Medical Care Facilities peers
Gross Profit (TTM)
5.24BEUR6.05B · vs all stocks (USD)
EBITDA (TTM)
3.63BEUR4.19B · vs all stocks (USD)
Net Income (TTM)
595.63MEUR687.52M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-4.60%vs Medical Care Facilities peers
Operating Cash Flow (TTM)
2.41BEUR2.78B · vs all stocks (USD)
Levered Free Cash Flow (TTM)
1.40BEUR1.62B · vs all stocks (USD)
Payout Ratio
55.17%vs Medical Care Facilities peers
Minority Interest (Equity)
972.98MEURFY2025 · Dec 31, 2025Revenue
19.63BEURFY2025 · Dec 31, 2025Cost of Goods Sold
14.60BEURFY2025 · Dec 31, 2025Gross Profit
5.03BEURFY2025 · Dec 31, 2025Operating Income
1.83BEUR2.11B · vs all stocks (USD)
Pre-tax Income
1.51BEURFY2025 · Dec 31, 2025Income Tax Expense
320.97MEURFY2025 · Dec 31, 2025Net Income
1.19BEURFY2025 · Dec 31, 2025EBIT
1.90BEURFY2025 · Dec 31, 2025EBITDA (Income Statement)
3.58BEURFY2025 · Dec 31, 2025Research & Development
157.97MEURFY2025 · Dec 31, 2025Selling, General & Administrative
3.03BEURFY2025 · Dec 31, 2025Other Operating Expenses
11.40MEURFY2025 · Dec 31, 2025Non-operating Interest Income
69.61MEURFY2025 · Dec 31, 2025Non-operating Interest Expense
384.41MEURFY2025 · Dec 31, 2025EPS (Basic)
3.36EURFY2025 · Dec 31, 2025EPS (Diluted)
3.36EURFY2025 · Dec 31, 2025Basic Shares Outstanding
291.19MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
291.19MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
1.19BEURFY2025 · Dec 31, 2025Minority Interests (P&L)
-212.90MEURFY2025 · Dec 31, 2025Operating Cash Flow
2.88BEURFY2025 · Dec 31, 2025Free Cash Flow
1.98BEURFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
1.60BEURFY2025 · Dec 31, 2025Starting Profit (CF Statement)
1.19BEURFY2025 · Dec 31, 2025Depreciation & Amortization
1.50BEURFY2025 · Dec 31, 2025Deferred Taxes (CF)
-27.21MEURFY2025 · Dec 31, 2025Other Non-cash Items
314.80MEURFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-69.06MEURFY2025 · Dec 31, 2025Change in Accounts Payable (CF)
12.45MEURFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-41.76MEURFY2025 · Dec 31, 2025Capital Expenditures
-898.67MEURFY2025 · Dec 31, 2025Net Acquisitions
180.17MEURFY2025 · Dec 31, 2025Purchase of Investments
-87.52MEURFY2025 · Dec 31, 2025Sale of Investments
83.50MEURFY2025 · Dec 31, 2025Net Investing Cash Flow
-722.53MEURFY2025 · Dec 31, 2025Long-term Debt Issuance
1.62BEURFY2025 · Dec 31, 2025Long-term Debt Payments
-1.63BEURFY2025 · Dec 31, 2025Net Short-term Debt Issuance
15.65MEURFY2025 · Dec 31, 2025Common Stock Repurchase
-585.28MEURFY2025 · Dec 31, 2025Common Dividends Paid
-422.51MEURFY2025 · Dec 31, 2025Other Financing Charges
-544.99MEURFY2025 · Dec 31, 2025Net Financing Cash Flow
-1.54BEURFY2025 · Dec 31, 2025Shares Outstanding
270.09MSharesUpdated Jul 15, 2026Float Shares
198.90MSharesUpdated Jul 15, 2026% Held by Insiders
32.17%vs all stocks
% Held by Institutions
38.91%vs all stocks
Total Cash (MRQ)
1.36BEUR1.57B · vs all stocks (USD)
Total Cash per Share (MRQ)
4.64EURUpdated Jul 15, 2026Total Debt (MRQ)
13.07BEUR15.08B · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.8751xvs Medical Care Facilities peers
Current Ratio (MRQ)
1.26xvs Medical Care Facilities peers
Book Value per Share (MRQ)
46.11EURUpdated Jul 15, 2026Total Assets
31.00BEUR35.79B · vs all stocks (USD)
Total Current Assets
7.90BEURFY2025 · Dec 31, 2025Total Liabilities
16.72BEURFY2025 · Dec 31, 2025Total Non-current Assets
23.10BEURFY2025 · Dec 31, 2025Total Non-current Liabilities
10.47BEURFY2025 · Dec 31, 2025Total Current Liabilities
6.25BEURFY2025 · Dec 31, 2025Cash & Cash Equivalents
1.58BEURFY2025 · Dec 31, 2025Other Short-term Investments
238.77MEURFY2025 · Dec 31, 2025Accounts Receivable
3.16BEURFY2025 · Dec 31, 2025Inventory
2.14BEURFY2025 · Dec 31, 2025Accounts Payable
835.55MEURFY2025 · Dec 31, 2025Short-term Debt
2.20BEURFY2025 · Dec 31, 2025Deferred Revenue
114.36MEURFY2025 · Dec 31, 2025Other Current Liabilities
1.44BEURFY2025 · Dec 31, 2025Long-term Debt
8.60BEURFY2025 · Dec 31, 2025Other Non-current Liabilities
60.36MEURFY2025 · Dec 31, 2025Common Stock (Book)
293.41MEURFY2025 · Dec 31, 2025Retained Earnings
12.21BEURFY2025 · Dec 31, 2025Total Shareholders' Equity
14.28BEUR16.49B · vs all stocks (USD)
Treasury Stock
586.09MEURFY2025 · Dec 31, 202552-Week Low
34.60EURUpdated Jul 15, 202652-Week High
47.81EURUpdated Jul 15, 202652-Week Change
-9.65%vs all stocks
Beta
0.9148xvs all stocks
50-Day MA
38.96EURUpdated Jul 15, 2026200-Day MA
40.19EURUpdated Jul 15, 2026Avg 10-Day Volume
31.37KSharesUpdated Jul 15, 2026Avg 30-Day Volume
39.20KSharesUpdated Jul 15, 2026Diluted EPS (TTM)
2.03EURUpdated Jul 15, 2026Other Income / Expense
212.00KEURFY2025 · Dec 31, 2025Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
Prioritizing buybacks over growth reinvestmentNotable
Buyback Intensity: 0.04Revenue Growth YoY: 0.01
Financial Health
Altman Z-Score 2: grey zoneSignificant
Altman Z-Score: 2.00
High earnings qualityNotable
Earnings Quality Score: 2.18
Supply Chain
Downstream position: depends on 12 industries, supplies 7Notable
Outgoing: 7.00Incoming: 12.00
High connectivity hub: 19 industry connectionsNotable
Total Connections: 19.00
Scale
Revenue is $22.65B, higher than 95% of all stocks globallySignificant
Revenue (USD): 22,650,011,015.578Global P95: 14,667,937,174.886
Levered free cash flow is $1.62B, higher than 95% of all stocks globallySignificant
Levered free cash flow (USD): 1,616,822,166.139Global P95: 1,123,592,359.78
Market cap is $17.55B, above the global median of $1.15BNotable
Market cap (USD): 17,545,126,851.104Global Median: 1,146,734,693.424
Companies that share the same coordination system — how they create, deliver, or capture value.
Posco Holdings Inc.
Tier 1ProductionThroughput-Bound ConversionFlowRisk
Ganfeng Lithium Group Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Ieet Systems Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Neste Oyj
Tier 1ProductionThroughput-Bound ConversionFlowRule
SAIC Motor Corporation Limited
Tier 1ProductionThroughput-Bound ConversionFlowInterface
Ningbo Deye Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Talen Energy Corporation
Tier 1ProductionThroughput-Bound ConversionFlowRisk
Itt Inc.
Tier 1ProductionThroughput-Bound ConversionFlowRisk
Novonesis (Novozymes) B
Tier 1ProductionThroughput-Bound ConversionFlowRule
Eve Energy Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowSenseMaking